Icast
Payments companies reported to CMS as associated with Icast. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Icast, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Icast
These are the largest totals companies reported as associated with Icast. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jean Panneton | Virginia Beach, VA | Vascular Surgery | $17,569.15 |
| Allan Conway | San Francisco, CA | Vascular Surgery | $11,582.12 |
| Sharif Ellozy | New York, NY | Vascular Surgery | $6,623.00 |
| Nicholas Swerdlow | Boston, MA | Vascular Surgery | $6,057.20 |
| James Anderson | Fort Worth, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $5,110.00 |
| Neri Cohen | Baltimore, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $5,000.00 |
| Christopher Durham | Kingwood, TX | Vascular Surgery | $3,452.50 |
| Luis Sanchez | Saint Louis, MO | Vascular Surgery | $3,098.10 |
| William Brinkman | Plano, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $2,000.00 |
| Edwin Gravereaux | Boston, MA | Vascular Surgery | $962.50 |
Prescribed Icast?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.